Common Stock |
9 Months Ended |
|---|---|
Sep. 30, 2025 | |
| Equity [Abstract] | |
| Common Stock | 7. Common Stock
At September 30, 2025, the Company had 131,903,029 shares of common stock outstanding (December 31, 2024 - 131,903,029 shares).
The calculation of the basic and diluted loss per share for the nine months ended September 30, 2025 was based on the loss attributable to common stockholders of $630,907 (September 30, 2024 - $610,054) and a weighted average number of shares of common stock outstanding of 131,903,029 (September 30, 2024 - 131,903,029 shares).
At September 30, 2025, 10,050,000 stock options were excluded from the diluted weighted average number of shares calculation as their effect would have been anti-dilutive (December 31, 2024 - 10,050,000 stock options).
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|